nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Meta-Analysis: Comparative Efficacy and Safety of ADHD Medication
August 17, 2018   

A recent meta-analysis compared the efficacy and tolerability of oral medications for attention deficit hyperactivity disorder...
 Continue reading (Members only)
FDA Does Not Approve Sublingual Buprenorphine Spray for Pain
August 13, 2018   

The FDA has opted not to approve a new formulation of the opioid medication...
 Continue reading (Members only)
FDA Approves Once-Monthly Risperidone Injection
August 10, 2018   

A once-a-month, subcutaneous formulation of the atypical antipsychotic risperidone (called Perseris®) has now been approved...
 Continue reading
Tentative Hope for an Anti-amyloid Antibody
August 3, 2018   

With no effective agent yet available for the treatment of Alzheimer's disease (AD), Phase 2b clinical trial results for a novel agent (BAN2401) have recently offered tentative hope...
 Continue reading
Repetitive Transcranial Magnetic Stimulation in US Veterans With Treatment-Resistant Depression
July 21, 2018   

A recent study examined the effect of repetitive transcranial magnetic stimulation on US veterans with treatment-resistant major depression...
 Continue reading (Members only)
New Injectable Formulation of Aripiprazole Approved
July 16, 2018   

The FDA has now approved a NanoCrystal® injectable formulation of the atypical antipsychotic aripiprazole (Alkermes' Aristada Initio) for the treatment of schizophrenia in adults...
 Continue reading (Members only)
Lithium Use During Pregnancy and Maternal and Infant Outcomes
July 13, 2018   

Lithium is a staple and highly effective medication for the treatment of bipolar disorder; however, past data have indicated somewhat mixed data regarding the teratogenic effects of lithium use during pregnancy...
 Continue reading
Stress and Neurodevelopment
July 11, 2018   

Researchers studied 37 individuals from early childhood through adolescence and examined the impact of negative life events and negative social experiences on brain development...
 Continue reading (Members only)
FDA Approves First Cannabis-Derived Medication
July 3, 2018   

The US Food and Drug Administration (FDA) has approved the first cannabis-based medicine to treat drug resistant childhood epilepsies...
 Continue reading (Members only)
Novel Approach to Treating Posttraumatic Stress Disorder
June 27, 2018   

A novel approach to the treatment of combat-related post-traumatic stress disorder (cr-PTSD) could play a significant role in helping British veterans overcome PTSD, a new Cardiff University research project suggests...
 Continue reading
12345678910...
Top of Page